FT Logo (1).png
Field Trip Health Ltd. Common Shares to Trade on the OTCQX Best Market
January 28, 2021 07:55 ET | Field Trip Health, Ltd.
TORONTO, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, is pleased to...
FT Logo (1).png
Field Trip Health Ltd. Announces Opening of Field Trip Health Center in Atlanta, GA, as it Continues Expansion in the US
January 26, 2021 07:30 ET | Field Trip Health, Ltd.
ATLANTA, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP, OTCBB: FTRPF) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today...
FT Logo (1).png
Field Trip Health Ltd. Announces Participation in a MAPS-sponsored Multi-Site Study of MDMA-Assisted Therapy to Treat Eating Disorders
January 07, 2021 07:30 ET | Field Trip Health, Ltd.
TORONTO, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP) (OTCBB: FTRPF) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, is pleased to announce...
FT Logo (1).png
Field Trip Health Ltd. Announces Closing of Bought Deal Financing
January 05, 2021 09:28 ET | Field Trip Health, Ltd.
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (“Field Trip” or the “Company”)...
FT Logo (1).png
Field Trip Health Ltd. Provides Operational and Investor Update, Announces Expanded Hours at its Field Trip Health Center in Toronto plus Rollout of Portal, Field Trip’s Proprietary Digital Mental Health Platform
December 03, 2020 07:55 ET | Field Trip Health, Ltd.
TORONTO, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP) (OTCBB: FTRPF) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, is pleased to announce...
FT Logo (1).png
Field Trip Health Ltd. Reports Second Fiscal Quarter 2021 Financial Results, Announces Two New Field Trip Health Center Locations
November 30, 2020 17:05 ET | Field Trip Health, Ltd.
Pre-clinical studies demonstrate potential of FT-104, its novel psychedelic molecule, as preferable option for psychedelic therapies, with comparable potency to psilocybin and shorter duration4 Field...
FT Logo (1).png
Field Trip Health Ltd. Schedules Second Fiscal Quarter 2021 Financial Results Conference Call for Tuesday, December 1, 2020 at 8:00 am ET
November 25, 2020 07:55 ET | Field Trip Health, Ltd.
TORONTO, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP, OTCBB: FTRPF) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today...
FT Logo (1).png
Field Trip Health Ltd. and WHOOP announce partnership to measure effect of psychedelic therapies on physiology and mental health
November 19, 2020 07:55 ET | Field Trip Health, Ltd.
TORONTO, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP, OTCBB: FTRPF) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, and WHOOP, the...
FT Logo (1).png
Field Trip Health Ltd. Announces Expansion to The Netherlands and Launch of Proprietary Truffle Program
November 17, 2020 07:55 ET | Field Trip Health, Ltd.
AMSTERDAM, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP, OTCBB: FTRPF) ("Field Trip"), a global leader in the development and delivery of technology-enabled psychedelic...
FT Logo (1).png
Field Trip Health Ltd. Prepares to Enter Oregon Market following the Passage of Measure 109 in Oregon, Creating the First Legal Market for Psilocybin Services
November 05, 2020 07:55 ET | Field Trip Health, Ltd.
TORONTO, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP) ("Field Trip"), one of the leaders in the development and delivery of psychedelic therapies, announced today that it is...